FDA Drug/Biologics Approval BLA 103532, DORNASE ALFA
FDA Drug/Biologics Approval BLA 103532, DORNASE ALFA
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
BLA 103532
Company: GENENTECH
Drug Name: PULMOZYME
Active Ingredients: DORNASE ALFA
Strength: 1MG/ML
Dosage Form/Route: VIAL
Action Date: 12/30/1993
Marketing Status: Prescription
Submission Classification: ORIG-1
Company: GENENTECH
Drug Name: PULMOZYME
Active Ingredients: DORNASE ALFA
Strength: 1MG/ML
Dosage Form/Route: VIAL
Action Date: 12/30/1993
Marketing Status: Prescription
Submission Classification: ORIG-1
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details